Mequinol

Summary

Mequinol (CHEMBL544) is an approved small molecule (ATC D11AX06).

At a glance

• Status: Approved (max clinical phase 4)
• Modality: Small molecule
• ATC class: D11AX06
• Chemistry: 124.14 Da · C7H8O2

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL544
Name	Mequinol
Type	Small molecule
Max phase	4
FDA approved	no
PubChem CID	9015
ATC	D11AX06
Molecular formula	C7H8O2
Molecular weight	124.14
InChIKey	NWVVVBRKAWDGAB-UHFFFAOYSA-N

SMILES: COC1=CC=C(C=C1)O

IUPAC name: 4-methoxyphenol

Also known as: 4ha, BMS-181158, Hqmme; hydroxyquinone methyl ether, Leucobasal, Leucodine b, Mechinolum, Menthyl anthranilate, Mequinol, Mequinol component of solage, Novo-dermoquinona, NSC-4960, P-guaiacol

Patent coverage: 36,353 distinct patent families (97,542 SureChEMBL compound mentions), from 1 matched compound structure(s). Mentions count patents naming the compound (not distinct inventions), so promiscuous / reference molecules inflate the mention figure — families are the dedup metric.

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.

Clinical trials

Total trials: 0.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).